A detailed history of Ghost Tree Capital, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 150,000 shares of PCVX stock, worth $17 Million. This represents 4.62% of its overall portfolio holdings.

Number of Shares
150,000
Previous 95,000 57.89%
Holding current value
$17 Million
Previous $6.49 Million 74.54%
% of portfolio
4.62%
Previous 2.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$60.06 - $78.77 $3.3 Million - $4.33 Million
55,000 Added 57.89%
150,000 $11.3 Million
Q1 2024

May 15, 2024

BUY
$59.79 - $81.05 $1.49 Million - $2.03 Million
25,000 Added 35.71%
95,000 $6.49 Million
Q4 2023

Feb 14, 2024

SELL
$45.35 - $63.41 $3.17 Million - $4.44 Million
-70,000 Reduced 50.0%
70,000 $4.4 Million
Q3 2023

Nov 14, 2023

SELL
$46.0 - $53.1 $6.44 Million - $7.43 Million
-140,000 Reduced 50.0%
140,000 $7.14 Million
Q2 2023

Aug 14, 2023

BUY
$34.66 - $54.07 $1.91 Million - $2.97 Million
55,000 Added 24.44%
280,000 $14 Million
Q1 2023

May 15, 2023

BUY
$36.27 - $47.2 $2.36 Million - $3.07 Million
65,000 Added 40.63%
225,000 $8.43 Million
Q4 2022

Feb 14, 2023

SELL
$20.58 - $47.95 $4.12 Million - $9.59 Million
-200,000 Reduced 55.56%
160,000 $7.67 Million
Q3 2022

Nov 14, 2022

BUY
$21.69 - $28.53 $759,150 - $998,550
35,000 Added 10.77%
360,000 $8.64 Million
Q2 2022

Aug 15, 2022

BUY
$17.68 - $26.58 $442,000 - $664,500
25,000 Added 8.33%
325,000 $7.07 Million
Q1 2022

May 16, 2022

BUY
$17.46 - $26.36 $873,000 - $1.32 Million
50,000 Added 20.0%
300,000 $7.25 Million
Q4 2021

Feb 16, 2022

BUY
$19.32 - $26.45 $1.74 Million - $2.38 Million
90,000 Added 56.25%
250,000 $5.95 Million
Q3 2021

Nov 15, 2021

BUY
$20.26 - $26.97 $303,900 - $404,550
15,000 Added 10.34%
160,000 $4.06 Million
Q2 2021

Aug 11, 2021

BUY
$16.45 - $24.06 $2.39 Million - $3.49 Million
145,000 New
145,000 $3.26 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $6.71B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.